Markus Puhlmann is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Feb 2023 and Mar 2024: Perspective Therapeutics, Inc. (Seattle, WA — biotechnology — 2023–2024; $87.4M reported sold to 54 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Frank Morich (3 shared filings), Johan (Thijs) Spoor (3 shared filings), Jonathan Hunt (3 shared filings), Lori Woods (3 shared filings), Mark Austin (3 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Markus. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Markus Puhlmann and found 3 differences: Form D filed 18 days after the first sale; Industry group changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.